Giroctocogene Fitelparvovec
Giroctocogene Fitelparvovec Uses, Dosage, Side Effects, Food Interaction and all others data.
Giroctocogene Fitelparvovec is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).
| Trade Name | Giroctocogene Fitelparvovec |
| Generic | Giroctocogene fitelparvovec |
| Giroctocogene fitelparvovec Other Names | Aav2/6-b-domain-deleted blood coagulation factor viii, Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying), Giroctocogene fitelparvovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Giroctocogene Fitelparvovec
